A Bow of Blue / music by Max Dreyfus; words by Maurice J. Steinberg

Cover: drawing of a young lady taking a promenade, as a cherubim touches a blue bow in her hair; text reads: Supplement to the Newark Sunday News, June 9th, 1901; Publisher: T. B. Harms and Co. (New York)https://egrove.olemiss.edu/sharris_b/1008/thumbnail.jp

Because the Fortune Teller Told Me / music by Howard and Emmerson; words by Howard and Emmerson and Maurice J. Steinberg

Cover: drawing of an African American male listening to a fortune teller with outlayed cards; photo inset of John E. Brennan and Florence Sinnott; Publisher: T. B. Harms and Co. (New York)https://egrove.olemiss.edu/sharris_b/1007/thumbnail.jp

Evidence of water ice near the lunar poles

Lunar Prospector epithermal neutron data were studied to evaluate the probable chemical state of enhanced hydrogen, [H], reported previously to be near both lunar poles [1,2]. Improved versions of thermal and epithermal neutron data were developed for this purpose. Most important is the improved spatial resolution obtained by using shortened integration times. A new data set was created, Epi* = [Epithermal - 0.057 x Thermal], to reduce effects of composition variations other than those due to hydrogen. The Epi* counting rates are generally low near both lunar poles and high over terrane near recent impact events such as Tycho and Jackson. However, other lunar features are also associated with high Epi* rates, which represent a wide range of terrane types that seem to have little in common. If we postulate that one property all bright Epi* features do have in common is low [H], then measured Epi* counting rates appear to be quantitatively self consistent. If we assume that [H]=O above the top 98th percentile of Epi* counting rates at 2{sup o} x 2{sup o} spatial resolution, then [H]{sub ave} = 55 ppm for latitudes equatorward of [75{sup o}]. This value is close to the average found in returned lunar soil samples, [H]{sub ave} {approx} 50 ppm [3]. Using the foregoing physical interpretation of Epi* counting rates, we find that the Epi* counts within most of the large craters poleward of {+-}70{sup o} are higher, and therefore [H] is lower, than that in neighboring inter-crater plains, as shown in Figure 1. Fourteen of these craters that have areas larger than the LP epithermal spatial resolution (55 km diameter at 30 km altitude), were singled out for study. [H] is generally found to increase with decreasing distance from the poles (hence decreasing temperature). However, quantitative estimates of the diffusivity of hydrogen at low temperature show that diffusion can not be an important factor in explaining the difference between the relatively low [H] observed within the large sunlit polar craters and the relatively high [H] in neighboring inter-crater plains. A closer look at the 'inter-crater' plains near the poles, shows that they are covered by many small craters that harbor permanent shade [4]. The temperatures within many of these craters are low enough [5] that they can disable sublimation as a viable loss process of [H{sub 2}O]. It is therefore tempting to postulate that the enhanced hydrogen within most regions of permanent shade is in the form of water molecules. This postulate is certainly viable within the bottoms of several large, permanently shaded craters near the south pole. Predicted temperatures within them [5] fall well below the 100 K temperature that is needed to stabilize water ice for aeons. The picture is different near the north pole. Here, there are relatively few permanently-shaded craters that are large enough to harbor temperatures that are sufficiently low to stabilize water ice indefinitely against sublimation [5]. Instead, the 'inter-crater' polar plains are a jumble of many permanently-shaded craters that have diameters less than 10 km [4]. Although simulations of temperatures within this class of craters show they are only marginally cold enough to indefinitely stabilize water ice [5], this terrane appears to have the highest [H]. Nevertheless, predicted temperatures are close enough to that needed to permanently stabilize [H{sub 2}O] to suggest that sublimation is indeed the process that discriminates between polar terrane that contains enhanced [H] and those that do not (see, e.g., the temperature estimates for doubly-shaded craters [6]). If correct, then an important fraction of the hydrogen near the north pole must be in the form of H{sub 2}O, which then resides within these small craters. Estimates using our improved data set of [H] within craters near the south pole remain unchanged from those derived from our previous analysis [2], [H] = 1700{+-}900 ppm. This translates to [H{sub 2}O]=1.5{+-}0.8%. If all of the enhanced hydrogen in the north is in the form of H{sub 2}O and is confined to the jumble of small permanently-shaded craters identified by radar [4], then we can estimate their water-ice fraction, [H{sub 2}O], using Figure 1a in [2]. We chose two regions near the north pole for this purpose. They each have areas just larger than the surface foot-print of the LP epithermal neutron spectrometer. The first was an inter-crater region nestled between Rozhdestvenskiy and Plaskett, and the second covered the southeast comer of Peary. Using Figure 3 of [4], the first area contains 232 km{sup 2} of measured permanent shade, and the second contains 129 km{sup 2}. Adopting the prescription used in Table 1 of [4] for estimating actual from sampled shaded areas, multiplication of sampled areas by 1.5 yields permanently shaded areas that amount to 350 km{sup 2} in region 1, and 200 km{sup 2} in the southeast comer of Peary

Cyclic Nucleotide Phosphodiesterases and Compartmentation in Normal and Diseased Heart

International audienceCyclic nucleotide phosphodiesterases (PDEs) degrade the second messengers cAMP and cGMP, thereby regulating multiple aspects of cardiac function. This highly diverse class of enzymes encoded by 21 genes encompasses 11 families which are not only responsible for the termination of cyclic nucleotide signalling, but are also involved in the generation of dynamic microdomains of cAMP and cGMP controlling specific cell functions in response to various neurohormonal stimuli. In myocardium, the PDE3 and PDE4 families are predominant to degrade cAMP and thereby regulate cardiac excitation-contraction coupling. PDE3 inhibitors are positive inotropes and vasodilators in human, but their use is limited to acute heart failure and intermittent claudication. PDE5 is particularly important to degrade cGMP in vascular smooth muscle, and PDE5 inhibitors are used to treat erectile dysfunction and pulmonary hypertension. However, these drugs do not seem efficient in heart failure with preserved ejection fraction. There is experimental evidence that these PDEs as well as other PDE families including PDE1, PDE2 and PDE9 may play important roles in cardiac diseases such as hypertrophy and heart failure. After a brief presentation of the cyclic nucleotide pathways in cardiac cells and the major characteristics of the PDE superfamily, this chapter will present their role in cyclic nucleotide compartmentation and the current use of PDE inhibitors in cardiac diseases together with the recent research progresses that could lead to a better exploitation of the therapeutic potential of these enzymes in the future

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements